Some cannabis/marijuana products and solutions include amounts of cannabinoids that differ substantially from what’s said on their labels. In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify cannabis as being a Routine III drug. This rescheduling